Bring Back OTA--Congress' Own Think Tank

Scientists cheered in 1972 when Congress created the Office of Technology Assessment, a PhD-laden think tank that was dedicated to providing policy analyses and technical evaluations for the House and Senate. They wept in 1995, when, in a burst of political pique and boastful penny-pinching, Newt Gingrich and his Republican Revolution abolished OTA. Resuscitation efforts started then, and continue--in futility. Thus, in the current Congress, Rep. Rush Holt (D-NJ), one of the few scientists i

Written byDaniel Greenberg
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Scientists cheered in 1972 when Congress created the Office of Technology Assessment, a PhD-laden think tank that was dedicated to providing policy analyses and technical evaluations for the House and Senate. They wept in 1995, when, in a burst of political pique and boastful penny-pinching, Newt Gingrich and his Republican Revolution abolished OTA.

Resuscitation efforts started then, and continue--in futility. Thus, in the current Congress, Rep. Rush Holt (D-NJ), one of the few scientists in Congress, reintroduced the Office of Technology Reestablishment Act. Like its predecessors, the bill disappeared into the black hole of legislative losers, never heard of again. In today's political climate, with former Speaker Gingrich's ideological kinsmen still ascendant, the restoration movement is becalmed. All the more reason to keep alive fading memories of OTA's achievements while recognizing the failings that contributed to its demise--and waiting hopefully for a swing of the political pendulum.

By many measures, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies